Sonic Healthcare Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Sonic Healthcare yıllık ortalama 0.7% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar declining at 3.3% annual. Gelirler growing yılda ortalama 6.1% oranında artmaktadır. Sonic Healthcare'in özkaynak karlılığı 6.7% ve net marjı 5.7%'dir.

Anahtar bilgiler

0.7%

Kazanç büyüme oranı

0.5%

EPS büyüme oranı

Healthcare Sektör Büyümesi	2.4%
Gelir büyüme oranı	6.1%
Özkaynak getirisi	6.7%
Net Marj	5.7%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Sonic Healthcare nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

CHIA:SHL Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	8,967	511	250
31 Mar 24	8,680	508	241
31 Dec 23	8,392	505	232
30 Sep 23	8,281	595	225
30 Jun 23	8,169	685	217
31 Mar 23	8,417	850	215
31 Dec 22	8,666	1,015	213
30 Sep 22	9,003	1,238	210
30 Jun 22	9,340	1,461	206
31 Mar 22	9,209	1,463	231
31 Dec 21	9,078	1,465	255
30 Sep 21	8,916	1,390	251
30 Jun 21	8,754	1,315	248
31 Mar 21	8,339	1,133	240
31 Dec 20	7,923	951	233
30 Sep 20	7,378	739	231
30 Jun 20	6,832	528	229
31 Mar 20	6,703	554	289
31 Dec 19	6,573	581	350
30 Sep 19	6,353	565	430
30 Jun 19	6,134	550	510
31 Mar 19	5,952	510	500
31 Dec 18	5,770	470	489
30 Sep 18	5,655	473	481
30 Jun 18	5,541	476	472
31 Mar 18	5,430	468	466
31 Dec 17	5,319	460	460
30 Sep 17	5,220	444	454
30 Jun 17	5,122	428	449
31 Mar 17	5,081	444	450
31 Dec 16	5,040	460	450
30 Sep 16	5,029	456	447
30 Jun 16	5,018	451	444
31 Mar 16	4,829	406	425
31 Dec 15	4,639	362	407
30 Sep 15	4,420	355	389
30 Jun 15	4,201	348	372
31 Mar 15	4,115	365	361
31 Dec 14	4,029	382	350
30 Sep 14	3,971	383	341
30 Jun 14	3,913	385	331
31 Mar 14	3,799	373	319
31 Dec 13	3,685	362	307

Kaliteli Kazançlar: SHL yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: SHL 'nin mevcut net kar marjları (5.7%) geçen yılın (8.4%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: SHL şirketinin kazancı son 5 yılda yılda 0.7% oranında arttı.

Büyüme Hızlandırma: SHL 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: SHL geçtiğimiz yıl negatif kazanç büyümesine ( -25.4% ) sahipti ve bu da onu Healthcare sektör ortalamasıyla ( -25.4% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: SHL 'nin Özsermaye Getirisi ( 6.7% ) düşük olarak değerlendiriliyor.

Sonic Healthcare Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Recent updates

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited, Annual General Meeting, Nov 19, 2024

Final dividend of AU$0.63 announced

Sonic Healthcare Limited Declares Final Dividend for the Six Months Ended 30 June 2024, Payable on 19 September 2024

Full year 2024 earnings released: EPS: AU$1.07 (vs AU$1.46 in FY 2023)

Sonic Healthcare Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Sonic in the Running for Healius Imaging Business

New minor risk - Shareholder dilution

Upcoming dividend of AU$0.43 per share

First half dividend increased to AU$0.43

First half 2024 earnings released: EPS: AU$0.43 (vs AU$0.81 in 1H 2023)

Sonic Healthcare Limited to Report First Half, 2024 Results on Mar 20, 2024

Sonic Healthcare Limited (ASX:SHL) signed binding agreements to acquire Pathology Watch Inc. for $130 million.

Finance Director recently sold AU$1.3m worth of stock

Upcoming dividend of AU$0.62 per share at 3.2% yield

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on 21 September, 2023

Full year 2023 earnings released: EPS: AU$1.46 (vs AU$3.06 in FY 2022)

Sonic Healthcare Limited to Report Fiscal Year 2023 Results on Aug 17, 2023

Now 20% undervalued after recent price drop

Sonic Healthcare Limited (ASX:SHL) signed an binding agreement to acquire synlab Suisse SA from SYNLAB International GmbH for CHF 150 million.

Upcoming dividend of AU$0.42 per share at 3.1% yield

First half 2023 earnings released

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 22, 2023

Sonic Healthcare Limited to Report First Half, 2023 Results on Feb 16, 2023

CEO, MD & Executive Director recently sold AU$9.9m worth of stock

Sonic Healthcare Limited Announces Board Changes

Sonic Healthcare Limited, Annual General Meeting, Nov 17, 2022

Sonic Healthcare Limited, Annual General Meeting, Nov 27, 2022

Upcoming dividend of AU$0.60 per share

Full year 2022 earnings released: EPS: AU$3.06 (vs AU$2.76 in FY 2021)

Sonic Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 September, 2022

Insufficient new directors

Upcoming dividend of AU$0.40 per share

Sonic Healthcare Limited (ASX:SHL) announces an Equity Buyback for AUD 500 million worth of its shares.

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Sonic Healthcare Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 23, 2022

Sonic Healthcare Limited (ASX:SHL) acquired ProPath Laboratory, Inc.

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

CEO, MD & Executive Director recently sold AU$8.4m worth of stock

Upcoming dividend of AU$0.55 per share

Full year 2021 earnings released: EPS AU$2.76 (vs AU$1.11 in FY 2020)

Sonic Healthcare Limited (ASX:SHL) signed a binding agreement to acquire Canberra Imaging Group.

Rhythm Biosciences Adds Sonic Clinical Services to Colostat Clinical Trial

New 90-day low: AU$31.39

First half 2021 earnings released: EPS AU$1.42 (vs AU$0.54 in 1H 2020)

Revenue beats expectations

Sonic Healthcare Limited to Report First Half, 2021 Results on Feb 18, 2021

Sonic Healthcare Limited to Report Fiscal Year 2021 Results on Aug 18, 2021

Sonic Healthcare Limited Elects Professor Suzanne Crowe as A Director

Sonic Healthcare Limited Do Not Provide Earnings Guidance for the Fiscal Year 2021 Due to COVID-19

Earnings released

New 90-day high - AU$34.66

Sonic Healthcare Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day high - AU$33.38

New 90-day high - AU$31.60

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin